Items where authors include "Ng, CE"

Article

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2023) Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (10). pp. 1083-1092. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Guthrie, EA orcid.org/0000-0002-5834-6616, Ng, CE et al. (2 more authors) (2023) Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (3). pp. 323-334. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome. Neurogastroenterology & Motility. e14483. ISSN 1350-1925

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living. Alimentary Pharmacology and Therapeutics (AP&T), 56 (5). pp. 844-856. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Alimentary Pharmacology & Therapeutics, 56 (1). pp. 110-120. ISSN 0269-2813

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 55 (10). pp. 1311-1319. ISSN 0269-2813